Michiko Tawada

660 citations

19 papers · 422 indexed · h-index 11

Co-authors: Shinichi Imamura Akira Hori Hiroshi Miki Hidehisa Iwata Naoki Miyamoto Akiyoshi Tani Yasuhiro Imaeda Hironobu Maezaki
Topics: Neuropeptides and Animal Physiology (4 papers)Computational Drug Discovery Methods (3 papers)Peptidase Inhibition and Analysis (3 papers)
Cited by: Toxicology Organic Chemistry Molecular Biology
Journals: Biochemical and Biophysical Research Communications Journal of Medicinal Chemistry Bioorganic & Medicinal Chemistry
Partner nations: Japan United States Canada

In The Last Decade

Michiko Tawada

17 papers receiving 412 citations

Peers

Countries citing papers authored by Michiko Tawada

Since Specialization

Citations

This map shows the geographic impact of Michiko Tawada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiko Tawada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiko Tawada more than expected).

Fields of papers citing papers by Michiko Tawada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiko Tawada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiko Tawada. The network helps show where Michiko Tawada may publish in the future.

Co-authorship network of co-authors of Michiko Tawada

This figure shows the co-authorship network connecting the top 25 collaborators of Michiko Tawada. A scholar is included among the top collaborators of Michiko Tawada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michiko Tawada. Michiko Tawada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Discovery of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 Main Protease through Computer-Aided Drug Design 2025 ·Journal of Medicinal Chemistry ·(unknown),Daniel W. Carney,Michiko Tawada,(unknown),Jumpei Aida,Terufumi Takagi,Douglas R. Dougan,Abba E. Leffler,(unknown),Leah L. Frye,Eileen Hickey,(unknown),(unknown),Jangir Selimkhanov,Kazuko Yonemori,(unknown),Kumar Singh Saikatendu,Atsuko Ochida	0
2	Integration of Synthetic Organic Chemistry and <i>in silico</i> Drug Discovery - Lead Discovery of Renin Inhibitors and <i>O</i>-GlcNAcase Inhibitors 2023 ·Journal of Synthetic Organic Chemistry Japan ·Michiko Tawada	0
3	Discovery of a Novel Series of Potent, Selective, Orally Available, and Brain-Penetrable C1s Inhibitors for Modulation of the Complement Pathway 2023 ·Journal of Medicinal Chemistry ·(unknown),(unknown),Yusuke Sasaki,Matthew Reynolds,Nozomu Sakai,Masato Yoshikawa,Michiko Tawada,(unknown),Douglas R. Dougan,Chien‐Hung Chen,Irena Levin,Hua Zou,Masako Kuno,Naoto Arimura,Yusuke Kikukawa,Mitsuyo Kondo,Kimio Tohyama,Kenjiro Sato	7
4	Discovery of a Novel and Brain-Penetrant O -GlcNAcase Inhibitor via Virtual Screening, Structure-Based Analysis, and Rational Lead Optimization 2021 ·Journal of Medicinal Chemistry ·Michiko Tawada,Makoto Fushimi,(unknown),(unknown),Noriko Uchiyama,Yohei Kosugi,Weston Lane,Richard Tjhen,Satoshi Endo,Tatsuki Koike	10
5	Identification of a selective DDX3X inhibitor with newly developed quantitative high-throughput RNA helicase assays 2020 ·Biochemical and Biophysical Research Communications ·(unknown),Masahiro Nogami,Misa Iwatani,Toshihiro Imaeda,Masahiro Ito,Toshio Tanaka,Michiko Tawada,Satoshi Endo,Douglas R. Cary,Momoko Ohori,Yasuhiro Imaeda,Tomohiro Kawamoto,Samuel Aparício,Atsushi Nakanishi,Shinsuke Araki	10
6	Identification of 2,6-Disubstituted 3H-Imidazo[4,5-b]pyridines as Therapeutic Agents for Dysferlinopathies through Phenotypic Screening on Patient-Derived Induced Pluripotent Stem Cells 2019 ·Journal of Medicinal Chemistry ·(unknown),(unknown),Michiko Tawada,(unknown),(unknown),Tatsuo Oikawa,(unknown),Tomoya Sameshima,Kazumasa Miyamoto,Makoto Miyamoto,Yuko Kokubu,Ryuichi Tozawa,Hidetoshi Sakurai,Bunnai Saito	6
7	Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents 2017 ·Bioorganic & Medicinal Chemistry ·(unknown),Naoki Tomita,Youichi Kawakita,Y. ITO,(unknown),(unknown),T. Miyazaki,Kazuko Yonemori,Michiko Tawada,Hiroyuki Sumi,Yoshihiko Satoh,Yukiko Yamamoto,Ikuo Miyahisa,Masako Sasaki,Yoshinori Satomi,Megumi Hirayama,Ryuichi Nishigaki,Hironobu Maezaki	28
8	Design of potent dipeptidyl peptidase IV (DPP-4) inhibitors by employing a strategy to form a salt bridge with Lys554 2017 ·Bioorganic & Medicinal Chemistry Letters ·Hironobu Maezaki,Michiko Tawada,Takashi Yamashita,(unknown),Yasufumi Miyamoto,Yoshio Yamamoto,(unknown),Takuo Kosaka,Shigetoshi Tsubotani,Akiyoshi Tani,Tomoko Asakawa,Nobuhiro Suzuki,Satoru Oi	17
9	Structure-based design of a new series of N-(piperidin-3-yl)pyrimidine-5-carboxamides as renin inhibitors 2016 ·Bioorganic & Medicinal Chemistry ·Yasuhiro Imaeda,Michiko Tawada,(unknown),(unknown),Mitsuyo Kondo,Naoki Tarui,Tsukasa Sanada,(unknown),G. Snell,Craig A. Behnke,Keiji Kubo,Takanobu Kuroita	11
10	Novel approach of fragment-based lead discovery applied to renin inhibitors 2016 ·Bioorganic & Medicinal Chemistry ·Michiko Tawada,(unknown),Yasuhiro Imaeda,Hideyuki Oki,Gyorgy Snell,Craig A. Behnke,Mitsuyo Kondo,Naoki Tarui,Toshimasa Tanaka,Takanobu Kuroita,(unknown)	6
11	Design, synthesis, and evaluation of novel VEGFR2 kinase inhibitors: Discovery of [1,2,4]triazolo[1,5-a]pyridine derivatives with slow dissociation kinetics 2013 ·Bioorganic & Medicinal Chemistry ·Yuya Oguro,Douglas R. Cary,Naoki Miyamoto,Michiko Tawada,Hidehisa Iwata,Hiroshi Miki,Akira Hori,Shinichi Imamura	38
12	Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors 2013 ·Bioorganic & Medicinal Chemistry ·Shigemitsu Matsumoto,Naoki Miyamoto,Takaharu Hirayama,Hideyuki Oki,Kengo Okada,Michiko Tawada,Hidehisa Iwata,Kazuhide Nakamura,Seiji Yamasaki,Hiroshi Miki,Akira Hori,Shinichi Imamura	48
13	Discovery of Potent Mcl-1/Bcl-xL Dual Inhibitors by Using a Hybridization Strategy Based on Structural Analysis of Target Proteins 2013 ·Journal of Medicinal Chemistry ·Yuta Tanaka,Katsuji Aikawa,Goushi Nishida,Misaki Homma,Satoshi Sogabe,S. Igaki,(unknown),Tomoya Sameshima,Ikuo Miyahisa,Tomohiro Kawamoto,Michiko Tawada,Yumi Imai,Masakazu Inazuka,Nobuo Cho,Yasuhiro Imaeda,Tomoyasu Ishikawa	91
14	A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases 2012 ·ACS Medicinal Chemistry Letters ·Hidehisa Iwata,Hideyuki Oki,Kengo Okada,Terufumi Takagi,Michiko Tawada,Yasushi Miyazaki,Shinichi Imamura,Akira Hori,J. David Lawson,Mark S. Hixon,Hiroyuki Kimura,Hiroshi Miki	25
15	Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Takashi Yamashita,Asato Kina,Michiko Tawada,Satoshi Endo,Atsushi Mizukami,Masako Sasaki,Akiyoshi Tani,(unknown),(unknown),Naoki Furuyama,Miyuki Funami,Nobuyuki Amano,K. Fukatsu	35
16	Discovery, synthesis, and structure–activity relationship of 6-aminomethyl-7,8-dihydronaphthalenes as human melanin-concentrating hormone receptor 1 antagonists 2011 ·Bioorganic & Medicinal Chemistry ·(unknown),(unknown),Toshihiro Imaeda,Toshio Tanaka,Jun Terauchi,Maki Miyamoto,(unknown),Michiko Tawada,Satoshi Endo,Shiro Takekawa,(unknown),Nobuhiro Suzuki,(unknown),(unknown),Kaoru Watanabe,(unknown),Koki Kato,Kaneyoshi Kato,Yuji Ishihara	9
17	Melanin-concentrating hormone receptor 1 antagonists: Synthesis, structure–activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives 2011 ·Bioorganic & Medicinal Chemistry ·(unknown),Masahiro Kamaura,(unknown),Kazuyoshi Aso,(unknown),(unknown),Kaoru Watanabe,(unknown),Michiko Tawada,(unknown),Shiro Takekawa,Koki Kato,Nobuhiro Suzuki,Yuji Ishihara	13
18	Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554 2011 ·Bioorganic & Medicinal Chemistry ·Hironobu Maezaki,(unknown),Yasufumi Miyamoto,(unknown),Tomoko Asakawa,Osamu Kataoka,Koji Takeuchi,Nobuhiro Suzuki,(unknown),Takuo Kosaka,Masako Sasaki,Shigetoshi Tsubotani,Akiyoshi Tani,Miyuki Funami,Yoshio Yamamoto,Michiko Tawada,Kathleen Aertgeerts,Jason K. Yano,Satoru Oi	28
19	Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: A new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554 2011 ·Bioorganic & Medicinal Chemistry ·(unknown),Yasufumi Miyamoto,Mitsuru Sasaki,Satoru Oi,Tomoko Asakawa,Osamu Kataoka,Koji Takeuchi,Nobuhiro Suzuki,(unknown),Takuo Kosaka,Shigetoshi Tsubotani,Akiyoshi Tani,Miyuki Funami,Michiko Tawada,Yoshio Yamamoto,Kathleen Aertgeerts,Jason K. Yano,Hironobu Maezaki	40

About Michiko Tawada

Michiko Tawada is a scholar working on Oncology, Cellular and Molecular Neuroscience and Computational Theory and Mathematics, having authored 19 papers that have together received 422 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (4 papers), Computational Drug Discovery Methods (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Toxicology (25 citations), Organic Chemistry (185 citations) and Molecular Biology (219 citations). Michiko Tawada has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Shinichi Imamura, Akira Hori, Hiroshi Miki, Hidehisa Iwata, Naoki Miyamoto, Akiyoshi Tani, Yasuhiro Imaeda, Hironobu Maezaki, Hideyuki Oki and Ikuo Miyahisa. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact